Paul Tudor Jones’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-40,217
Closed -$3.4M 4278
2026
Q1
$4M Buy
+40,217
New +$5.25M 0.01% 1315
2025
Q4
Sell
-4,138
Closed -$519K 4055
2025
Q3
$464K Sell
4,138
-119,578
-97% -$14M ﹤0.01% 2742
2025
Q2
$16.6M Buy
123,716
+18,890
+18% +$2.07M 0.04% 411
2025
Q1
$7.05M Buy
+104,826
New +$7.21M 0.02% 631
2024
Q3
Sell
-11,303
Closed -$1.74M 3109
2024
Q2
$1.7M Buy
11,303
+4,552
+67% +$546K 0.01% 1169
2024
Q1
$499K Sell
6,751
-80,190
-92% -$6.61M ﹤0.01% 1648
2023
Q4
$6.86M Buy
86,941
+48,110
+124% +$2.9M 0.06% 486
2023
Q3
$2.13M Buy
+38,831
New +$2.8M 0.02% 899
2023
Q2
Sell
-40,582
Closed -$3.07M 2929
2023
Q1
$3.07M Sell
40,582
-35,628
-47% -$2.46M 0.05% 574
2022
Q4
$4.7M Sell
76,210
-6,796
-8% -$361K 0.09% 272
2022
Q3
$3.46M Buy
83,006
+74,584
+886% +$3.24M 0.07% 330
2022
Q2
$265K Buy
+8,422
New +$225K 0.01% 1642

Other funds holding TMDX

Paul Tudor Jones's TMDX Position: Q2 2026 in Review

Paul Tudor Jones sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 40,217 shares — an estimated $3.4M sold.

Paul Tudor Jones first reported a position in TMDX in Q2 2022 and held it in 12 quarters. The position peaked at $16.6M in Q2 2025. 371 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Paul Tudor Jones reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 40,217 Transmedics shares in Q2 2026, an estimated $3.4M.
  • Paul Tudor Jones first reported a position in Transmedics in Q2 2022 and held it in 12 quarters.
  • Paul Tudor Jones's Transmedics position peaked at $16.6M in Q2 2025.
  • 371 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.